Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas

Roswarski Joseph; Roschewski Mark; Lucas Andrea; Melani Christopher; Pittaluga Stefania; Jaffe Elaine S.; Steinberg Seth M.; Waldmann Thomas A.; Wilson Wyndham H.

首页> 外文期刊>Leukemia and lymphoma >Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas

【24h】

Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas

机译：抗CD2单克隆抗体，Siplizumab的I相剂量升级研究，具有Da-Epoch-R在侵蚀性外周T细胞淋巴瘤中

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

团队文献服务 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Leukemia and lymphoma 》 |2018年第6期| 共4页
作者
Roswarski Joseph; Roschewski Mark; Lucas Andrea; Melani Christopher; Pittaluga Stefania; Jaffe Elaine S.; Steinberg Seth M.; Waldmann Thomas A.; Wilson Wyndham H.;
展开▼
作者单位

NCI Ctr Canc Res Bethesda MD 20892 USA;

NCI Ctr Canc Res Bethesda MD 20892 USA;

NCI Ctr Canc Res Bethesda MD 20892 USA;

NCI Ctr Canc Res Bethesda MD 20892 USA;

NCI Pathol Lab Bldg 10 Bethesda MD 20892 USA;

NCI Pathol Lab Bldg 10 Bethesda MD 20892 USA;

NCI Ctr Canc Res Bethesda MD 20892 USA;

NCI Ctr Canc Res Bethesda MD 20892 USA;

NCI Ctr Canc Res Bethesda MD 20892 USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类肿瘤学 ;
关键词

相似文献

外文文献
中文文献
专利

1. Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas [J] . Roswarski Joseph, Roschewski Mark, Lucas Andrea, Leukemia and lymphoma . 2018 ,第5a6期

机译：抗CD2单克隆抗体，Siplizumab的I相剂量升级研究，具有Da-Epoch-R在侵蚀性外周T细胞淋巴瘤中
2. Multicenter phase II study of mogamulizumab (KW-0761), a defucosylated anti-cc chemokine receptor 4 antibody, in patients with relapsed peripheral T-cell lymphoma and cutaneous T-cell lymphoma. [J] . Michinori Ogura, Takashi Ishida, Kiyohiko Hatake, Journal of Clinical Oncology . 2014 ,第11期

机译：多加糖单抗抗cc趋化因子受体4抗体mogamulizumab（KW-0761）的多中心II期研究，用于复发性外周T细胞淋巴瘤和皮肤T细胞淋巴瘤患者。
3. Phase I study of KW-0761, a defucosylated humanized anti-CCR4 antibody, in relapsed patients with adult T-cell leukemia-lymphoma and peripheral T-cell lymphoma. [J] . Yamamoto K, Utsunomiya A, Tobinai K, Journal of Clinical Oncology . 2010 ,第9期

机译：KW-0761是一种去岩藻糖基化的人源化抗CCR4抗体，用于成人T细胞白血病-淋巴瘤和外周T细胞淋巴瘤的复发患者的I期研究。
4. Efficient Acquisition of Antigen-Specific Human Monoclonal Antibody by Using Peripheral Blood Mononuclear Cells Immunized In Vitro Efficient Cloning of Human Monoclonal Antibody Gene [C] . Shinei Matsumoto, Makiko Yamashita, Yoshinori Katakura, Annual Meeting of the Japanese Association for Animal Cell Technology . 2009

机译：通过使用在体外克隆人单克隆抗体基因的体外克隆的外周血单核细胞高效采集抗原特异性人单克隆抗体
5. Molecular Characterization of Canine Peripheral T-Cell Lymphoma [D] . Harris, Lauren . 2020

机译：犬外周T细胞淋巴瘤的分子表征
6. Phase I dose escalation study of the anti-CD2 monoclonal antibody siplizumab with DA-EPOCH-R in aggressive peripheral T-cell lymphomas [O] . Joseph Roswarski, Mark Roschewski, Andrea Lucas, -1

机译：抗CD2单克隆抗体siplizumab与DA-EPOCH-R在侵袭性外周T细胞淋巴瘤中的I期剂量递增研究
7. European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma [O] . Zinzani, Pier Luigi, Karlin, Lionel, Radford, John, 2016

机译：Mogamulizumab（抗CCR4单克隆抗体）在复发/难治性外周T细胞淋巴瘤中的欧洲II期研究
8. Humanized Monoclonal Antibody Specific to the Extracellular Domain of PSMA: Dose Escalation Trial in Patients with Prostate Cancer [R] . Vallabhajosula, S. 2003

机译：psma细胞外区特异性人源化单克隆抗体：前列腺癌患者的剂量递增试验

Phase I dose escalation study of the anti-CD2 monoclonal antibody, siplizumab, with DA-EPOCH-R in aggressive peripheral T-cell lymphomas

著录项

相似文献

相关主题

期刊订阅